196 related articles for article (PubMed ID: 35159073)
1. Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC.
Moree SE; Maneix L; Iakova P; Stossi F; Sahin E; Catic A
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159073
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway.
Ye D; Wang S; Wang X; Lin Y; Huang Y; Chi P
Bioengineered; 2022 Apr; 13(4):9106-9116. PubMed ID: 35354355
[TBL] [Abstract][Full Text] [Related]
4. Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1.
Sun XX; Challagundla KB; Dai MS
EMBO J; 2012 Feb; 31(3):576-92. PubMed ID: 22124327
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
Xu Y; Xu M; Tong J; Tang X; Chen J; Chen X; Zhang Z; Cao B; Stewart AK; Moran MF; Wu D; Mao X
Blood; 2021 Mar; 137(11):1478-1490. PubMed ID: 32842143
[TBL] [Abstract][Full Text] [Related]
6. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.
Saldana M; VanderVorst K; Berg AL; Lee H; Carraway KL
Endocr Relat Cancer; 2019 Jan; 26(1):R1-R14. PubMed ID: 30400005
[TBL] [Abstract][Full Text] [Related]
7. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.
Sun XX; He X; Yin L; Komada M; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3734-9. PubMed ID: 25775507
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1.
Zhu D; Xu R; Huang X; Tang Z; Tian Y; Zhang J; Zheng X
Cell Death Differ; 2021 Jun; 28(6):1773-1789. PubMed ID: 33328570
[TBL] [Abstract][Full Text] [Related]
9. Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.
Maneix L; Iakova P; Moree SE; Hsu JI; Mistry RM; Stossi F; Lulla P; Sun Z; Sahin E; Yellapragada SV; Catic A
Cancer Res Commun; 2022 Dec; 2(12):1693-1710. PubMed ID: 36846090
[TBL] [Abstract][Full Text] [Related]
10. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo.
Wang P; Joberty G; Buist A; Vanoosthuyse A; Stancu IC; Vasconcelos B; Pierrot N; Faelth-Savitski M; Kienlen-Campard P; Octave JN; Bantscheff M; Drewes G; Moechars D; Dewachter I
Acta Neuropathol; 2017 May; 133(5):731-749. PubMed ID: 28083634
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.
Han X; Ren C; Lu C; Qiao P; Yang T; Yu Z
Cell Death Differ; 2022 Sep; 29(9):1864-1873. PubMed ID: 35296795
[TBL] [Abstract][Full Text] [Related]
12. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
13. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation.
Zhao X; Lv S; Li N; Zou Q; Sun L; Song T
J Biol Chem; 2024 Apr; 300(4):107152. PubMed ID: 38462165
[TBL] [Abstract][Full Text] [Related]
14. USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc.
Ge J; Yu W; Li J; Ma H; Wang P; Zhou Y; Wang Y; Zhang J; Shi G
J Exp Clin Cancer Res; 2021 Feb; 40(1):59. PubMed ID: 33546726
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis.
Feng L; Wang K; Tang P; Chen S; Liu T; Lei J; Yuan R; Hu Z; Li W; Yu X
Aging (Albany NY); 2020 Oct; 12(19):19273-19292. PubMed ID: 33051403
[TBL] [Abstract][Full Text] [Related]
16. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer.
Pan J; Deng Q; Jiang C; Wang X; Niu T; Li H; Chen T; Jin J; Pan W; Cai X; Yang X; Lu M; Xiao J; Wang P
Oncogene; 2015 Jul; 34(30):3957-67. PubMed ID: 25284584
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinating c-Myc: USP36 steps up in the nucleolus.
Sun XX; Sears RC; Dai MS
Cell Cycle; 2015; 14(24):3786-93. PubMed ID: 26697836
[TBL] [Abstract][Full Text] [Related]
18. Structural basis and specificity of human otubain 1-mediated deubiquitination.
Edelmann MJ; Iphöfer A; Akutsu M; Altun M; di Gleria K; Kramer HB; Fiebiger E; Dhe-Paganon S; Kessler BM
Biochem J; 2009 Mar; 418(2):379-90. PubMed ID: 18954305
[TBL] [Abstract][Full Text] [Related]
19. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.
Kumari R; Kumar R; Kumar S; Singh AK; Hanpude P; Jangir D; Maiti TK
J Biol Chem; 2020 Mar; 295(11):3466-3484. PubMed ID: 32005664
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion.
Edelmann MJ; Kramer HB; Altun M; Kessler BM
FEBS J; 2010 Jun; 277(11):2515-30. PubMed ID: 20553488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
